Efficacy and Safety of Humanized Anti-Cd19-Car-T Therapy Following Intensive Lymphodepleting Chemotherapy for Refractory/Relapsed B Acute Lymphoblastic Leukaemia
British Journal of Haematology - United Kingdom
doi 10.1111/bjh.16623
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 31, 2020
Authors
Publisher
Wiley